The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 12, 2013

Filed:

Jul. 19, 2012
Applicants:

Alan Korman, Piedmont, CA (US);

Mark Selby, San Francisco, CA (US);

Kent B. Thuduim, Oakland, CA (US);

Edward Halk, Sunnyvale, CA (US);

Mohan Srinivasan, San Jose, CA (US);

David B. Passmore, San Carlos, CA (US);

Inventors:

Alan Korman, Piedmont, CA (US);

Mark Selby, San Francisco, CA (US);

Kent B. Thuduim, Oakland, CA (US);

Edward Halk, Sunnyvale, CA (US);

Mohan Srinivasan, San Jose, CA (US);

David B. Passmore, San Carlos, CA (US);

Assignee:

Medarex, L.L.C., Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to BTLA with high affinity. Nucleic acid molecules encoding the antibodies of the disclosure, expression vectors, host cells and methods for expressing the antibodies of the disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the disclosure are also provided. The disclosure also provides methods for detecting BTLA, as well as methods for treating various diseases, including cancer and infectious diseases, using anti-BTLA antibodies.


Find Patent Forward Citations

Loading…